“…1 International prevalence rates of EA/TEF currently range between 1.27 and 4.55 per 10,000 births. [2][3][4] Due to the complex nature and infrequency of cases, EA/TEF management remains a major therapeutic challenge for most pediatric surgeons and other involved specialists. 5,6 In most of the current reports, prematurity, low birth weight, and additional congenital anomalies are associated with higher mortality and further complicate the care of these patients, 7,8 whereas survival rates in full-term infants with no other abnormalities can approach 100% after EA/TEF surgery.…”